Innovation and technology (I&T) are important forces driving long-term economic development. The Hong Kong SAR Government has contacted more than 200 companies so far in its drive to attract innovative companies to the city, of which more than 25 had already settled or were planning to settle in Hong Kong, or expand their business scale in Hong Kong, with an investment of more than HK$17 billion (US$2.17 billion).
The global fisheries and aquaculture industry are evolving rapidly to increase resource efficiency, boost output sustainably improve food security. Aquaculture – farming freshwater fish and crustaceans – is developing more rapidly in emerging markets than mature ones, and is growing strongly in Hong Kong.
The Hong Kong Trade Development Council (HKTDC) helped the Chinese University of Hong Kong (CUHK) reach a research agreement with AI Medical Service (AIM) – a Japanese medical start-up which develops artificial intelligence (AI) endoscopic diagnostic technology – to accelerate development, promote it in Hong Kong and enhance clinical application in other Asian economies.
With the theme of Reimagining the Future of Healthcare, the third Asia Summit on Global Health (ASGH) runs in Hong Kong on 17 and 18 May. The conference assembles stakeholders – from healthcare experts to renowned academia and influential business leaders, together with key industry players, innovative start-ups, investors and policymakers – from around the world to exchange insights, explore opportunities and collaborate on the diverse and dynamic healthcare sector.
Hong Kong earlier this month hosted its second Asia Summit on Global Health (ASGH), as the city continues to garner international attention after further loosening COVID-19 restrictions. This year’s theme – “Charting a New Course in Healthcare through Collaboration” resonated strongly with Dr Zsuzsanna Jakab (main picture), Deputy Director-General of the World Health Organization. In her video speech at the event’s opening session, Dr Jakab said the pandemic had infected more than 600 million people globally and claimed 6.5 million lives, so there was an “opportunity and, indeed, an obligation to learn from this pandemic” and accelerate progress on universal healthcare through concerted efforts in science, research, innovation, data and digital technologies.
A professor at The Chinese University of Hong Kong (CUHK) has established a firm, EggLogics Limited (EggLogics), that has developed patented technology to increase the success rate for in-vitro fertilisation (IVF) through egg “recharging”, bringing new hope to families troubled by fertility problems.
Videos
Learn about latest market updates and insights to empower your business.